Moving towards Personalized Medicine in Muscle-Invasive Bladder Cancer: Where Are We Now and Where Are We Going?

Neoadjuvant cisplatin-based chemotherapy followed by radical cystectomy is the recommended treatment, with the highest level of evidence, for patients with muscle-invasive bladder cancer (MIBC). However, only a minority of patients receive this treatment, mainly due to patient comorbidities, the rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Pardo, Juan Carlos, Ruiz de Porras, Vicenç, Plaja, Andrea, Carrato, Cristina, Etxaniz, Olatz, Buisan, Oscar, Font, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503307/
https://www.ncbi.nlm.nih.gov/pubmed/32872531
http://dx.doi.org/10.3390/ijms21176271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503307/
https://www.ncbi.nlm.nih.gov/pubmed/32872531
http://dx.doi.org/10.3390/ijms21176271

Ejemplares similares